← SynDRA
PTEROSTILBENE
SynDRA canonical compound SYN0003470 — structure-anchored drug synonym record
| Clinical phase | Phase 2/Phase 3 |
|---|
| Primary target(s) | PTGS2 |
|---|
| Mechanism of action | Cyclooxygenase inhibitor |
|---|
All known targets
- PPARA
- PTGS2
- BCR-ABL1
- FAAH
- PTGS1
Mechanisms of action (all sources)
- PPAR receptor agonist
- Cyclooxygenase inhibitor
- cyclooxygenase inhibitor, ppar receptor agonist
- PPARA AGONIST
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- TTR
- CYP1A1
- CYP1B1
- HDAC6
- ALOX5
- NQO2
- NPC1
- TRPV1
- TDP1
- TARDBP
- RAC1
- RAB9A
- PLAU
- ABCB1
- MAPT
- MAPK1
- GMNN
- GLP1R
- GFER
- GAA
- CYP19A1
- BRCA1
- KDM4E
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- ABL1
- ALR
- BCR
- KCMA1
- KCMB1
- KCMB2
- KCMB4
- LRC26
Cross-references
Synonyms
- 4-(3,5-dimethoxystyryl)phenol
- Pterostilbene, (e)-
- Trans-pterostilbene
- Pterostilbene component of eh-301
- (E)-4-(3,5-dimethoxystyryl)phenol
- 4-(3,5-Dimethoxystyryl)phenol
- 3',5'-Dimethoxy-4-stilbenol
- trans-pterostilbene
- 4-[(E)-2-(3,5-dimethoxyphenyl)ethenyl]phenol
- pterostilben
- 4-[(E)-2-(3,5-dimethoxyphenyl)vinyl]phenol
- UNII-26R60S6A5I
- 3,5-Dimethoxy-4'-hydroxy-trans-stilbene
- 3,5-Dimethoxy-4'-hydroxystilbene
- trans-3,5-dimethoxy-4'-hydroxystilbene
- CHEMBL83527
- CHEBI:8630
- VLEUZFDZJKSGMX-ONEGZZNKSA-N
- 4-((E)-2-(3,5-dimethoxyphenyl)ethenyl)phenol
- 26R60S6A5I
- Pterostilbene, Pterocarpus
- pterostilbene, (E)-
- Phenol, 4-[(1E)-2-(3,5-dimethoxyphenyl)ethenyl]-
- 4-[(1E)-2-(3,5-Dimethoxyphenyl)ethenyl]phenol
- Phenol, 4-[2-(3,5-dimethoxyphenyl)ethenyl]-
- 4-(2-(3,5-Dimethoxyphenyl)ethenyl)phenol
- phenol, 4-((1E)-2-(3,5-dimethoxyphenyl)ethenyl)-
- MFCD00238710
- SMR000440694
- 4-[2-(3,5-dimethoxyphenyl)ethenyl]phenol
- Pterostilbene, Pterocarpus marsupium
- 4-((1E)-2-(3,5-DIMETHOXYPHENYL)ETHENYL)PHENOL
- pTeroPure
- Tero-STILL-bean
- 3RL
- 4'-Hydroxy-3,5-dimethoxy-trans-stilbene
- CPD000440694
- 4-Stilbenol, 3',5'-dimethoxy-, (E)-
Look up PTEROSTILBENE in the interactive SynDRA portal →